Financials

  • Market Capitalization 470.67 M
  • Employee 23
  • Founded 2014
  • CEO N/A
  • Website www.ovidrx.com
  • Headquarter Delaware, United States
  • FIGI BBG009F0TD76
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-7.09
Rapporto prezzo/fatturato
16.57

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
2881
ALLO
Allogene Therapeutics, Inc. - Common Stock
1.40 USD-4.11%-6.67%-21.79%+13.82%483.69 M USD
2890
RZLT
Rezolute, Inc. - Common Stock
4.87 USD0.00%+4.96%+16.51%-37.96%471.04 M USD
2904
ASMB
Assembly Biosciences, Inc. - Common Stock
22.77 USD-3.23%-0.31%-24.88%-22.62%463.61 M USD
2906
AUTL
Autolus Therapeutics plc - American Depositary Shares
1.74 USD-3.87%-6.95%-6.45%+9.43%463.12 M USD

Notizie